Clinical Trial Update: A Trial Comparing the Effect of NN1250 After Different Routes of Injection in Healthy Subjects [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial evaluating NN1250 administered via different injection routes in healthy subjects to assess pharmacology and tolerability.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetes

Drugs mentioned

• NN1250

Snippet

Sponsor: Novo Nordisk A/S | Conditions: Diabetes, Healthy | Phase 1 | Status: COMPLETED